BRCA1 rs16942: What Your Genotype Means
The rs16942 variant is a common single nucleotide polymorphism (SNP) located within the BRCA1 gene. Research has investigated this variant as a potential modifier of breast cancer risk, particularly among individuals who already carry pathogenic BRCA1 mutations.
What each genotype means
Baseline risk profile
This genotype is considered the reference or common state for this variant. Research suggests that individuals with this genotype do not carry the specific allele associated with the slight increase in breast cancer risk observed in some studies.
This is a common genotype found across many global populations.
Slightly increased risk
Carrying one copy of the G allele is associated with a very slight increase in breast cancer risk in some research contexts. This variant is one of many small genetic factors that may cumulatively influence risk, and it should not be viewed as a diagnostic indicator on its own.
This genotype is common and observed frequently across diverse ancestral groups.
Slightly increased risk
Carrying two copies of the G allele is associated with a very slight increase in breast cancer risk in some research contexts. This variant is one of many small genetic factors that may cumulatively influence risk, and it should not be viewed as a diagnostic indicator on its own.
This genotype is common and observed frequently across diverse ancestral groups.
Understanding the rs16942 Variant
The rs16942 variant is a specific change in the DNA sequence of the BRCA1 gene. In genetics, a SNP represents a variation at a single position in the DNA chain. When researchers study rs16942, they are looking at whether having one version of the DNA letter versus another at this specific location correlates with health outcomes. This variant is considered common, meaning it appears frequently across various human populations. Because it sits within the BRCA1 gene, scientists have long been interested in whether it influences the gene's function or interacts with other genetic factors to alter disease susceptibility. It is important to note that rs16942 is not a pathogenic mutation that causes cancer on its own; rather, it is a common variation that researchers study to understand how subtle genetic differences might influence the risk profile of individuals, especially those who may have other hereditary predispositions.
The Role of the BRCA1 Gene
The BRCA1 gene provides instructions for making a protein that acts as a tumor suppressor. This protein is essential for repairing damaged DNA, which helps maintain the stability of a cell's genetic information. When the BRCA1 protein functions correctly, it prevents cells from growing and dividing too rapidly or in an uncontrolled way. Inherited pathogenic variants in BRCA1 can disrupt this repair process, significantly increasing the lifetime risk of developing breast, ovarian, and other cancers. Because of its critical role in DNA repair, the BRCA1 gene is one of the most studied genes in oncology. Researchers examine common variants like rs16942 to see if they act as 'modifiers'—genetic factors that might slightly increase or decrease the risk of cancer for people who carry a primary pathogenic BRCA1 mutation, or even for the general population.
Research and Evidence Strength
Evidence regarding rs16942 is considered moderate. Some studies have suggested that the minor allele of rs16942 on the 'wild-type' (non-mutated) copy of the BRCA1 gene may be associated with a decreased risk of breast cancer in women who are already carriers of a pathogenic BRCA1 mutation. For example, research published in journals like the American Journal of Human Genetics has indicated that individuals with specific genotypes at this locus showed a lower hazard ratio for breast cancer development. However, it is crucial to recognize that these findings are statistical associations observed in large cohorts and do not imply a direct cause-and-effect relationship for every individual. Other studies have sometimes yielded mixed results, which is common in genetic association research. Because the effect sizes are generally small, this variant is not used for clinical diagnosis or as a standalone predictor of cancer risk in a medical setting.
What This Information Means for You
If you have received information about your rs16942 genotype, it is important to understand that this is a research-level finding. This variant is not a diagnostic tool, and it cannot tell you whether you will or will not develop cancer. Genetic risk is complex and involves the interplay of many different genes, environmental factors, and lifestyle choices. You should never use this information to make medical decisions, such as changing screening schedules or pursuing preventative procedures. If you are concerned about your family history of cancer or your personal risk, the most appropriate step is to consult with a certified genetic counselor or a healthcare provider. They can help you interpret your overall genetic profile in the context of your personal and family medical history, ensuring that any decisions about your health are based on comprehensive clinical evaluation rather than a single genetic marker.
How common is this variant?
The rs16942 variant is a common SNP found across diverse human populations. Allele frequencies can vary by ancestry, and it is widely represented in global genetic databases.
Frequently asked questions
Is rs16942 a sign that I have breast cancer?
No, rs16942 is a common genetic variant and not a diagnostic test for cancer. It is a marker used in research to study small differences in risk, not a tool to detect the presence of disease.
Should I get tested for rs16942?
There is no clinical recommendation to test for this specific SNP. If you are concerned about your breast cancer risk, you should speak with a doctor or genetic counselor about clinical genetic testing for known pathogenic mutations.
Can I change my risk based on my rs16942 genotype?
Because this variant is a fixed part of your DNA, you cannot change it. However, you can always discuss healthy lifestyle choices and appropriate cancer screening schedules with your healthcare provider.
Why do studies show different results for this variant?
Genetic association studies often show varying results due to differences in study design, the ancestry of the participants, and the complex way multiple genes interact. This is why single SNPs are rarely used for individual medical predictions.
Sources & further reading
Educational information only, last refreshed 10/3/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs16942?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in BRCA1
This rare variant has been recently annotated in clinical databases as a potential contributor to hereditary breast and ovarian cancer risk.
Variant identified in polygenic risk scores for breast cancer susceptibility.
This variant is a rare genetic alteration in the BRCA1 gene, which is critical for DNA repair and associated with hereditary breast and ovarian cancer syndromes impacting reproductive health.
A very rare variant identified in recent genomic studies, currently being investigated for potential associations with reproductive phenotypes.
A rare variant located in the BRCA1 gene, relevant to reproductive genetic counseling and the assessment of hereditary cancer risk.
This BRCA1 variant (p.Pro871Leu) is a common polymorphism often evaluated in breast cancer risk studies, though it is generally considered to have no clinical significance for hereditary breast and ovarian cancer syndrome.